There are many consequences of untreated OSA, and all of these are more likely with more-severe obstruction. Because people ...

Obstructive sleep apnea (OSA) is very common with 15% to 30% of men in the United States and 10% to 15% of women having the ...

The Let’s Talk Smiles podcast announces its upcoming episode on sleep-related health issues, featuring sleep expert and ...

Try a single issue or save on a subscription Issues delivered straight to your door or device ...

The "Sleep Apnea Devices Market Forecast Report by Types, Therapeutic Devices, Diagnostic Devices, End User, Country and ...

New research provides guidance on the effects of caffeine, diet and naps on sleep. Plus there are expanded treatments for ...

Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...

Sleep expert Dr. Abhay Sharma talks about how Zepbound is now approved by the FDA for the treatment of moderate to severe ...

Treatment and management of CompSA can be complex. Diagnosis can also be challenging due to similarities in symptoms. While they have different causes and risk factors, all types of sleep apnea ...

Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.

Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...

Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment ...